Medtronic Endeavor approved in Japan
This article was originally published in The Gray Sheet
Executive Summary
Japan's Ministry of Health, Labor and Welfare approves Medtronic's Endeavor zotarolimus-eluting coronary stent, the firm announces March 30. Medtronic plans a launch in Japan as soon as it receives reimbursement authorization, which it expects May 1. The device gained U.S. approval in February 2008 and a CE mark in Europe in 2005